News
TEVA
13.15
-1.05%
-0.14
Teva And Alvotech: Simlandi Approval Opens New Generic Market Opportunities
Teva's stock has risen 32% since December, outperforming the SPY. FDA approval of Simlandi, a biosimilar to Humira, has been approved by the FDA. Teva and Alvotech are developing an arthritis injectable for the generic market. The company could become a preferred generic despite market competition for Humira.
Seeking Alpha · 19h ago
Why Freshpet Shares Are Trading Higher By Around 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Freshpet shares gained 15.5% to $106.29 on Monday. The company reported better-than-expected fourth-quarter financial results. Akili, Inc. Shares jumped 126% after the company reported positive results from a clinical trial of an ADHD drug in Japan.
Benzinga · 19h ago
Jefferies Just Raised Its Price Target on Salesforce (CRM) Stock
Jefferies analysts increased their price target for Salesforce (NYSE:CRM) stock by $25 to $350 per share. The sales data company's stock is up 1.7% as of Monday morning. Jefferies analysts also reiterated a ‘buy’ rating for the company’s stock. Salesforce stock is a hot topic after Jefferies increased their target for the stock. Teva Pharmaceutical stock jumped on government approval, Walmart stock undergoing a split and Nio securing a new tech deal.
Investorplace · 23h ago
TEVA Stock Pops 4% as Teva Receives FDA Approval
Alvotech’s (NASDAQ:ALVO) SIMLANDI injection to be used as an interchangeable biosimilar to Humira. Humira was one of the biggest pharmaceutical products of 2023 with $12.2 billion in sales. Teva Pharmaceutical (Teva) stock is up 3.8% as of Monday morning. This approval allows for Alvotech to launch the injection in the U.S.
Investorplace · 23h ago
Why Is Generic Drugs Player Teva Pharma Stock Trading Higher Today?
FDA approved Simlandi injection, as an interchangeable biosimilar to AbbVie Inc’s Humira. The biosimilar is indicated for adult arthritis. In 2023, Humira was one of the highest-grossing pharmaceutical products in the world.
Benzinga · 1d ago
Piper Sandler Sticks to Its Buy Rating for Teva Pharmaceutical (TEVA)
TipRanks · 1d ago
Teva and Jiangsu announce partnership for distribution of AUSTEDO in China
Healthcare Teva and Jiangsu announce partnership for distribution of AUSTEDO in China. AustEDO is used in the treatment of neurodegenerative and movement disorders. Teva Pharmaceutical Investments Singapore is a unit of Teva. The partnership intends to increase patients’ access to Teva’s AUSTedO.
Seeking Alpha · 1d ago
Li Auto Posts Q4 Earnings, Joins Teva Pharmaceutical And Other Big Stocks Moving Higher In Monday's Pre-Market Session
Shares of Li Auto Inc. Rose sharply in today’s pre-market trading after the company reported fourth-quarter financial results above estimates. U.S. Stock futures were lower this morning, with the Dow futures trading lower by over 50 points. The company reported sales of $5.88 billion in the fourth quarter.
Benzinga · 1d ago
Biggest stock movers today: Li Auto, Intuitive Machines, and more
Li Auto Inc. Stock surged past 7% following its impressive Q4 report. Teva Pharmaceutical's stock price increased by 5% following the FDA approval of a biosimilar to Humira. Intuitive Machines' stock plunged more than 30% after its spacecraft tipped over on the moon.
Seeking Alpha · 1d ago
Alvotech/Teva win FDA approval for Humira biosimilar
Seeking Alpha · 1d ago
Weekly Report: what happened at TEVA last week (0219-0223)?
Weekly Report · 1d ago
iShares Core MSCI Total International Stock ETF Experiences Big Inflow
NASDAQ · 5d ago
TEVA Quantitative Stock Analysis
NASDAQ · 6d ago
Teva Pharma CEO Dismisses Split Speculations Expects Significant Interest For Its API Business Divestiture: Report
Teva Pharmaceutical Industries will not split into two separate entities, CEO says. The company will continue to manage the generics business and its branded drugs. Teva's CEO says the two businesses will complement each other well. Teva Pharmaceutical Industries is a subsidiary of Valeant Pharmaceutical Industries.
Benzinga · 6d ago
Teva Pharmaceuticals Announces Positive Data For Anti-TL1A Asset
NASDAQ · 6d ago
More
Webull provides a variety of real-time TEVA stock news. You can receive the latest news about Teva Pharm through multiple platforms. This information may help you make smarter investment decisions.
About TEVA
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.